INR 595.0
(1.46%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 8.21 Billion INR | 3.12% |
2022 | 7.97 Billion INR | -18.93% |
2021 | 9.83 Billion INR | 29.72% |
2020 | 7.57 Billion INR | -11.42% |
2019 | 8.55 Billion INR | 14.61% |
2018 | 7.46 Billion INR | -5.09% |
2017 | 7.86 Billion INR | -8.17% |
2016 | 8.56 Billion INR | -31.87% |
2015 | 12.57 Billion INR | 185.02% |
2014 | 4.41 Billion INR | 19.17% |
2013 | 3.7 Billion INR | -1.2% |
2012 | 3.74 Billion INR | -20.38% |
2011 | 4.7 Billion INR | 15.3% |
2010 | 4.08 Billion INR | -4.67% |
2009 | 4.28 Billion INR | -32.38% |
2008 | 6.33 Billion INR | 143.46% |
2007 | 2.6 Billion INR | 152.42% |
2006 | 1.03 Billion INR | 38.88% |
2005 | 741.82 Million INR | 35.68% |
2004 | 546.75 Million INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | -24.57 Billion INR | -399.0% |
2023 FY | 8.21 Billion INR | 3.12% |
2023 Q4 | 8.21 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q1 | - INR | -100.0% |
2023 Q2 | 9.02 Billion INR | 0.0% |
2022 Q4 | 7.97 Billion INR | 0.0% |
2022 FY | 7.97 Billion INR | -18.93% |
2022 Q1 | - INR | -100.0% |
2022 Q2 | 8.3 Billion INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2021 Q4 | 9.83 Billion INR | 0.0% |
2021 Q2 | 7.76 Billion INR | 0.0% |
2021 FY | 9.83 Billion INR | 29.72% |
2021 Q1 | - INR | -100.0% |
2021 Q3 | - INR | -100.0% |
2020 Q2 | 8.77 Billion INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 Q4 | 7.57 Billion INR | 0.0% |
2020 FY | 7.57 Billion INR | -11.42% |
2020 Q1 | - INR | -100.0% |
2019 Q1 | - INR | -100.0% |
2019 Q2 | 8.9 Billion INR | 0.0% |
2019 Q3 | - INR | -100.0% |
2019 FY | 8.55 Billion INR | 14.61% |
2019 Q4 | 8.55 Billion INR | 0.0% |
2018 Q2 | 8.58 Billion INR | 0.0% |
2018 FY | 7.46 Billion INR | -5.09% |
2018 Q1 | - INR | -100.0% |
2018 Q4 | 7.46 Billion INR | 0.0% |
2018 Q3 | - INR | -100.0% |
2017 FY | 7.86 Billion INR | -8.17% |
2017 Q2 | 11.15 Billion INR | 0.0% |
2017 Q3 | - INR | -100.0% |
2017 Q1 | - INR | -100.0% |
2017 Q4 | 7.86 Billion INR | 0.0% |
2016 Q4 | 8.56 Billion INR | 0.0% |
2016 FY | 8.56 Billion INR | -31.87% |
2016 Q3 | - INR | -100.0% |
2016 Q2 | 13.95 Billion INR | 0.0% |
2016 Q1 | - INR | -100.0% |
2015 Q4 | 12.57 Billion INR | 0.0% |
2015 FY | 12.57 Billion INR | 185.02% |
2015 Q3 | - INR | -100.0% |
2015 Q2 | 12.96 Billion INR | 0.0% |
2015 Q1 | - INR | -100.0% |
2014 Q2 | 4.33 Billion INR | 0.0% |
2014 Q1 | - INR | -100.0% |
2014 FY | 4.41 Billion INR | 19.17% |
2014 Q4 | 4.41 Billion INR | 0.0% |
2014 Q3 | - INR | -100.0% |
2013 Q3 | - INR | -100.0% |
2013 FY | 3.7 Billion INR | -1.2% |
2013 Q1 | - INR | -100.0% |
2013 Q4 | 3.7 Billion INR | 0.0% |
2013 Q2 | 3.89 Billion INR | 0.0% |
2012 FY | 3.74 Billion INR | -20.38% |
2012 Q4 | 3.74 Billion INR | 0.0% |
2012 Q3 | - INR | -100.0% |
2012 Q2 | 3.93 Billion INR | 0.0% |
2011 Q4 | 4.7 Billion INR | 0.0% |
2011 FY | 4.7 Billion INR | 15.3% |
2010 FY | 4.08 Billion INR | -4.67% |
2009 FY | 4.28 Billion INR | -32.38% |
2008 FY | 6.33 Billion INR | 143.46% |
2007 FY | 2.6 Billion INR | 152.42% |
2006 FY | 1.03 Billion INR | 38.88% |
2005 FY | 741.82 Million INR | 35.68% |
2004 FY | 546.75 Million INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Ambica Agarbathies Aroma & Industries Limited | 1.09 Billion INR | -647.398% |
Bajaj Consumer Care Limited | 1.53 Billion INR | -437.245% |
BCL Industries Limited | 6.27 Billion INR | -31.064% |
Colgate-Palmolive (India) Limited | 13.22 Billion INR | 37.83% |
Cupid Limited | 186.52 Million INR | -4306.839% |
Dabur India Limited | 48.19 Billion INR | 82.945% |
Gillette India Limited | 8.59 Billion INR | 4.362% |
Godrej Consumer Products Limited | 58.97 Billion INR | 86.062% |
Hindustan Unilever Limited | 270.76 Billion INR | 96.964% |
Honasa Consumer Limited | 5.36 Billion INR | -53.135% |
JHS Svendgaard Laboratories Limited | 271.7 Million INR | -2925.292% |
Jyothy Labs Limited | 5.9 Billion INR | -39.151% |
Kaya Limited | 5.22 Billion INR | -57.397% |
Marico Limited | 32.52 Billion INR | 74.724% |
N.K Industries Limited | 22.4 Billion INR | 63.309% |
Procter & Gamble Hygiene and Health Care Limited | 10.83 Billion INR | 24.15% |
S H Kelkar and Company Limited | 11.88 Billion INR | 30.824% |